Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1557-1566

  Coutts, Angela A ^a,b   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Acetylcholine release; Anandamide; Cannabinoid receptor agonists; Cannabinoid receptor antagonist; Guinea pig small intestine; Inverse agonist; Myenteric plexus; SR141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACETYLCHOLINE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; NALOXONE; NORMORPHINE; PHYSOSTIGMINE; POLYSORBATE 80; RIMONABANT;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; GUINEA PIG; MALE; MUSCLE EXCITATION; MUSCLE TWITCH; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; CHILD, PRESCHOOL; CYCLOHEXANOLS; HISTAMINE; HUMANS; MALE; MORPHOLINES; MYENTERIC PLEXUS; NALOXONE; NAPHTHALENES; NOREPINEPHRINE; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STEREOISOMERISM;

EID: 0030814261     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701301     Document Type: Article

References (33)

1. COLQUHOUN, D. (1971). Lectures on Biostatistics. Oxford: Oxford University Press.
2. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586-594.
3. COUTTS, A.A., FERNANDO, S.R., GRIFFIN, G., NASH, J.E. & PERTWEE, R.G. (1995). Evidence that guinea-pig small intestine contains CB1 cannabinoid receptors and possibly also a cannabinoid receptor ligand. Br. J. Pharmacol. (Proc. suppl.), 116, 46P.
4. COWIE, A.L., KOSTERLITZ, H.W. & WATT, A.J. (1968). Mode of action of morphine-like drugs on autonomic neuro-effectors. Nature, 220, 1040-1042.
5. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
6. 2 receptors. Mol. Pharmacol., 48, 443-450.
7. GIFFORD, A.N. & ASHBY, C.R. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther., 277, 1431-1436.
8. GILL, E.W., PATON, W.D.M. & PERTWEE, R.G. (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature, 228, 134-136.
9. GREENBERG, R., KOSTERLITZ, H.W. & WATERFIELD, A.A. (1970). The effects of hexamethonium, morphine and adrenaline on the output of acetylcholine from the myenteric plexus-longitudinal muscle preparation of the ileum. Br. J. Pharmacol. Proc. Suppl., 40, 553P.
10. HERKENHAM, M. (1995). Localization of cannabinoid receptors in brain and periphery. In Cannabinoid Receptors, ed. Pertwee, R.G. pp. 145-166, London: Academic Press.
11. 1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 2023-2028.
12. KILBINGER, H. (1977). Modulation by oxotremorine and atropine of acetylcholine release evoked by electrical stimulation of the myenteric plexus of the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol., 300, 145-151.
13. 1-tetrahydrocannabinol and cannabidiol at cholinergic junctions. Br. J. Pharmacol Proc. Suppl., 41, 379P.
14. LEFF, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci., 16, 89-97.
15. LORD, J.A.H., WATERFIELD, A.A., HUGHES, J. & KOSTERLITZ, H.W. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature, 267, 495-499.
16. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINISKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEL, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
17. NORTH, R.A. & NISHI, S. (1974). Properties of the ganglion cells of the myenteric plexus of the guinea-pig ileum determined by intracellular recording. In Proc. Fourth. Int. Symp. Gastrointestinal motilily. ed. Daniel, E.E. pp. 667-676, Vancouver: Mitchell Press.
18. PATON, W.D.M., PERTWEE, R.G. & TEMPLE, D. (1972). The general pharmacology of cannabinoids. In Cannabis and Its Derivatives, ed. Paton, W.D.M. & Crown, J. pp. 50-75, Oxford: Oxford University Press.
19. PATON, W.D.M. & ZAR, M.A. (1968). The origin of acetylcholine released from the guinea-pig intestine and longitudinal muscle fibres. J. Physiol., 194, 13-33.
20. 1 receptors in mouse urinary bladder. Br. J. Pharmacol., 118, 2053-2058.
21. 8-tetrahydrocannabinol in two isolated tissue preparations. Eur. J. Pharmacol., 315, 195-201.
22. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
23. PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980-984.
24. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.-C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
25. ROTH, S.H. (1978). Stereospecific presynaptic inhibitory effect of delta-9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea-pig. Can. J. Physiol. Pharmacol., 56, 968-975.
26. SANTUCCI, V., STORME, J.-J., SOUBRIE, P. & LE FUR, G. (1996). Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, PL103-PL110.
27. SCHLICKER, F., TIMM, J. & GÖTHERT, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 791-795.
28. 2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989-999.
29. SUGIURA, T., KONDO, S., SUKAGAWA, A., NAKANE, S., SHINODA, A., ITOH, K., YAMASHITA, A. & WAKU, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
30. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci., 25, 637-654.
31. TEN BERGE, R.E.J., WEENING, E.C., ROFFEL, A.F. & ZAAGSMA, J. (1996). Differences in the prejunctional effects of methacholine and pilocarpine on the release of endogenous acetylcholine from guinea-pig trachea. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 606-611.
32. TERSIGNI, T.J. & ROSENBERG, H.C. (1996). Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA. Brain Res., 733, 184-192.
33. WATERFIELD, A.A. (1973). Factors Affecting Acetylcholine Release from the Myenteric Plexus of the Ileum. Ph.D. Thesis. University of Aberdeen.